Cvs Group Plc Stock Fundamentals

4C9 Stock  EUR 10.60  0.20  1.85%   
CVS Group plc fundamentals help investors to digest information that contributes to CVS Group's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Group stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CVS Group plc Company Current Valuation Analysis

CVS Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current CVS Group Current Valuation

    
  1.9 B  
Most of CVS Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Group plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition
In accordance with the recently published financial statements, CVS Group plc has a Current Valuation of 1.9 B. This is 89.52% lower than that of the sector and 62.25% lower than that of the Current Valuation industry. The current valuation for all Germany stocks is 88.59% higher than that of the company.

CVS Group plc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CVS Group's current stock value. Our valuation model uses many indicators to compare CVS Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CVS Group competition to find correlations between indicators driving CVS Group's intrinsic value. More Info.
CVS Group plc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.44  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CVS Group plc is roughly  2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CVS Group's earnings, one of the primary drivers of an investment's value.

CVS Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Group's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Group could also be used in its relative valuation, which is a method of valuing CVS Group by comparing valuation metrics of similar companies.
CVS Group is currently under evaluation in current valuation category among its peers.

CVS Fundamentals

About CVS Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CVS Group plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Group plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
CVS Group plc engages in veterinary, online pharmacy, and retail businesses. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom. CVS GROUP operates under Personal Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6150 people.

Currently Active Assets on Macroaxis

Other Information on Investing in CVS Stock

CVS Group financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS Group security.